| 저자 |
Byeong Yun Yang1, Min Jung Son2, Min Ji Shin1, Harin Rhee1, Eun Young Seong1, In Hae Hwang1,Kyeong Nam Lee3, Il Young Kim1, Dong Won Lee1, Soo Bong Lee1, Yeon Ju Lee2, Ihm Soo Kwak1 |
| 초록 |
Purpose: The prevalence of hypertension in young adults increases and contributes poor long-term outcomes to the
hypertension population. In clinical practice, many young hypertensive adults hardly reach a recommended level of
blood pressure (BP) with commonly used anti-hypertensives. While spironolactone is used as an add-on agent to resistant
hypertension, there are few reports describing its value as a beginner therapy in hypertension. We designed
a head to head study comparing spironolactone with barnidipine, a frequently prescribed calcium channel blocker
(CCB).
Material and Methods: We enrolled hypertension patients aged 19 to 40 years with their consent. The patients were
randomly assigned into a spironolactone group (SG; 50 mg maximally) and a barnidipine group (BG; 15 mg maximally).
We notified them of their study medication. To identify the effect in BP reduction, 24-hour ambulatory BP
monitoring (24-ABPM) was used between the initiation and completion of the study, of which the duration was 16
weeks. We also measured levels of hormones such as aldosterone, renin (plasma renin activity), cortisol, total testosterone,
sex hormone-binding globulin (SHBG), leptin, and insulin in the study (hypertensive) and healthy control
groups before entering run-in.
Results: Forty five patients were consecutively enrolled and 20 of them finally went through the randomization. Mean
ages were 21.5 and 22.1 in the SG and BG, respectively. Mean BMI (body mass index) of the SG patients was slightly
higher than that of the BG patients (27.1±2.3 vs. 26.2±1.2kg/m2). The initial mean systolic BP (SBP) by 24-ABPM
was not different between the 2 groups (149.2±15.4 mmHg in the SG vs. 153.8±17.2 mmHg in the BG, p>0.05).
At the end of the study, the mean SBP in the SG was statistically significantly more reduced than that of the BG
(SBP reduction: 17.2±11.3 mmHg in the SG vs. 12.0±12.4 mmHg, in the BG, p=0.032). In the analysis of hormones,
leptin, insulin, and SHBG showed significant differences between the study and control groups (Table 1).
Conclusions: As a single agent, spironolactone might be more effective to treat young male hypertensive adults than
barnidipine, one of the commonly used CCBs. It should be confirmed by long-term and large scale studies. |